|
|
Volumn 96 Suppl, Issue , 2009, Pages
|
|
Targeting KRAS pathway in NSCLC therapy;Stratégies thérapeutiques ciblant la voie KRAS dans le cancer bronchique non à petites cellules.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
FARNESYL TRANS TRANSFERASE;
LONAFARNIB;
MITOGEN ACTIVATED PROTEIN KINASE KINASE;
PIPERIDINE DERIVATIVE;
PYRIDINE DERIVATIVE;
QUINOLONE DERIVATIVE;
RAF PROTEIN;
RAS PROTEIN;
SORAFENIB;
TIPIFARNIB;
TUMOR PROTEIN;
ANIMAL;
ARTICLE;
DRUG ANTAGONISM;
GENETICS;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MOUSE;
MUTATION;
ONCOGENE RAS;
PHYSIOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, NON-SMALL-CELL LUNG;
FARNESYLTRANSTRANSFERASE;
GENES, RAS;
HUMANS;
LUNG NEOPLASMS;
MICE;
MITOGEN-ACTIVATED PROTEIN KINASE KINASES;
MUTATION;
NEOPLASM PROTEINS;
PIPERIDINES;
PYRIDINES;
QUINOLONES;
RAF KINASES;
RAS PROTEINS;
MLCS;
MLOWN;
|
|
EID: 75549083475
PISSN: None
EISSN: 17696917
Source Type: Journal
DOI: 10.1684/bdc.2009.0998 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
